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Excitatory synaptic currents in the mammalian brain are typi-
cally mediated by the neurotransmitter glutamate, acting at
AMPA receptors. We used immunocytochemistry to investigate
the distribution of AMPA receptor-binding protein (ABP) in the
cerebral neocortex. ABP was most prominent in pyramidal
neurons, although it was also present (at lower levels) in inter-
neurons. ABP and its putative binding partners, the GluR2/3
subunits of the AMPA receptor, exhibited prominent cellular
colocalization. Under appropriate processing conditions, colo-
calization could also be documented in puncta, many of which
could be recognized as dendritic spines. However, a sizable
minority of GluR2/3-positive puncta were immunonegative for
ABP. Because glutamate receptor-interacting protein (GRIP)
may also anchor GluR2, we studied the relative distribution of
ABP and GRIP. There was extensive colocalization of these two
antigens at the cellular level, although GRIP, unlike ABP, was
strongest in nonpyramidal neurons. Different parts of a single
dendrite could stain selectively for ABP or GRIP. To further
characterize this heterogeneity, we investigated punctate stain-
ing of neuropil using synaptophysin and the membrane tracer
DiA to identify probable synapses. Some puncta were compa-
rably positive for both ABP and GRIP, but the majority were
strongly positive for one antigen and only weakly positive or
immunonegative for the other. This heterogeneity could be seen
even within adjacent spines of a single dendrite. These data
suggest that ABP may act as a scaffold for AMPA receptors
either in concert with or independently from GRIP.
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Ionotropic glutamate receptors concentrate at the plasma mem-
brane overlying the excitatory postsynaptic density (PSD) (for
review, see Ottersen and Landsend, 1997; Conti and Weinberg,
1999; Nusser, 2000). Investigation of the molecular basis for this
phenomenon led to the discovery that PSD-95, a novel protein
concentrated at the PSD, binds to the NMDA receptor (for
review, see Kennedy, 1997; O’Brien et al., 1998). PSD-95 is one of
a family of proteins expressing PDZ domains, modular sites for
protein–protein interaction shared by PSD-95, the Discs-large
protein in Drosophila, and ZO-1, a protein found at the epithelial
zonula occludens (for review, see Ponting et al., 1997; Sheng and
Wyszynski, 1997). The second PDZ domain of PSD-95 binds to
the C-terminal motif of the NR2 subunit (Kornau et al., 1995;
Niethammer et al., 1996). Besides helping to anchor NMDA
receptors, PSD-95 may regulate second-messenger pathways by
bringing the receptor into proximity with downstream signaling
molecules such as the scaffolding molecule InaD, the PDZ do-
mains of which are crucial organizers of the Drosophila photo-
transduction cascade (for review, see Ziff, 1997; Craven and
Bredt, 1998; Migaud et al., 1998; Scott and Zuker, 1998).
Synapses in cerebral cortex and hippocampus commonly coex-
press NMDA and AMPA receptors (Bekkers and Stevens, 1989;
Kharazia et al., 1996; He et al., 1998; Takumi et al., 1999; Nusser,
2000). However, NMDA and AMPA receptors lie at different loci
within the synaptic active zone (Kharazia and Weinberg, 1997;
Somogyi et al., 1998). Yeast two-hybrid screens have identified
glutamate receptor-interacting protein (GRIP), a protein contain-
ing seven PDZ domains that can bind to the AMPA subunit GluR2
in vitro (Dong et al., 1999), and more recently, AMPA receptor-
binding protein (ABP), and its splice variant, ABP-L, sometimes
termed GRIP-2, a homologous protein coded on a different gene
(Srivastava et al., 1998; Bruckner et al., 1999; Dong et al., 1999;
Wyszynski et al., 1999). Biochemical evidence indicates an associ-
ation between several PDZ domains of ABP and the C termini of
the GluR2/3 subunits (Dong et al., 1999; Wyszynski et al., 1999),
but there is no structural evidence that ABP is actually associated
with synaptic glutamate receptors in intact brain. Moreover, it
remains unclear what the functional significance of two related
AMPA-binding proteins may be. Do they function in concert to
help organize the AMPA receptor signaling pathway, or do they
act independently? If the two proteins act cooperatively, both must
be at the same synapse. However, GRIP in cerebral neocortex
concentrates in specific classes of inhibitory local circuit neurons,
whereas the limited evidence available suggests a more widespread
distribution for ABP (Srivastava et al., 1998; Burette et al., 1999;
Dong et al., 1999).
These considerations motivated us to ask whether ABP colocal-
izes with GluR2/3, and if so, whether ABP and GRIP colocalize.
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We provide direct evidence for synaptic colocalization of ABP
with GluR2/3 in the adult cerebral cortex and document an unex-
pectedly complex pattern of colocalization between ABP and
GRIP.
MATERIALS AND METHODS
Antiserum. ABP antibody was generated by immunizing rabbits with a
peptide corresponding to amino acids 759–774, lying within its unique
C-terminal L2 region. An extra C-terminal Cys was included to permit
glutaraldehyde conjugation to keyhole limpet hemocyanin (KLH) (Sriv-
astava et al., 1998). This antibody recognizes both ABP and ABP-L/
GRIP-2. Two anti-GRIP antibodies were used. Antibody 1756/B.O. was
raised in rabbits against a hexahistidine-tagged fusion protein incorpo-
rating GRIP amino acids 664–1112, including PDZ6 and extending to
the C terminus of the protein (for characterization, see Wyszynski et al.,
1998, 1999). Because of concerns regarding possible cross-reaction, we
also used a second affinity-purified antibody that was generated by
immunizing rabbits with a peptide corresponding to GRIP amino acids
1084–1100 (SDWSEQNSAFFQQPSHG), conjugated to KLH through a
cysteine added to the N terminus of the peptide (S. deSouza and E. Ziff,
unpublished observations); this region of GRIP is not shared by ABP,
making the possibility of cross-reaction unlikely.
Tissue preparation. All procedures related to the care and treatment of
animals were in accordance with institutional and National Institutes of
Health guidelines. Nine male Sprague Dawley rats (200–350 gm)
(Charles River Laboratories, Raleigh NC) were used for this study.
Animals were deeply anesthetized with sodium pentobarbital (60 mg/kg,
i.p.). After intracardiac injection of heparin, six rats were perfused
through the heart with saline, followed by freshly depolymerized 4%
paraformaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4). Transverse
sections 20–70 mm thick were cut on a vibratome and collected in cold
PB. To assess whether limited antibody access consequent to aldehyde
cross-linking may influence results, we perfused five animals with 0.5%
paraformaldehyde, followed by a saline flush. In additional experiments,
we performed partial proteolysis on material fixed with 4% paraformal-
dehyde (Watanabe et al., 1998; Burette et al., 1999); before the immu-
nohistochemical incubations, sections were treated at 37°C for 10 min
with pepsin (2 U/ml in acetic acid, 0.5 M) (Sigma, St. Louis, MO).
To assess antibody specificity, we performed experiments on trans-
fected cells; C1-ABP (Wyszynski et al., 1999) (S. DeSouza, L. Khatri,
and E. B. Biff, unpublished observations) or GRIP expression plasmids
were introduced into HeLa cells using Effectene lipofection reagents
(Qiagen, Valencia, CA). At 48 hr after transfection, cells were fixed for
10 min in 0.5% depolymerized paraformaldehyde in PB or for 2 hr in 4%
paraformaldehyde in PB.
ABP immunostaining. For immunoperoxidase, free-floating sections
fixed with 4% paraformaldehyde were treated for 30 min with 3% H2O2
in PBS, pH 7.4 (to quench endogenous peroxidase activity), and then
preincubated in 10% normal donkey serum (to block secondary antibody
binding sites). Sections were incubated in primary antibody to ABP
(1:1000 dilution) overnight on a shaker at room temperature. Sections
were then incubated for 3 hr in biotinylated anti-rabbit antibody (1:200)
(Vector Laboratories, Burlingame, CA) and for 1 hr in ExtrAvidin-
peroxidase complex (1:5000) (Sigma); peroxidase was histochemically
visualized with diaminobenzidine. Processed sections were mounted on
gelatin-coated slides and coverslipped with DPX mountant (BDH Chem-
icals, Poole, UK).
For immunofluorescence, tyramide signal amplification (TSA) permit-
ted the use of primary antibody at dilutions of 1:10,000–1:20,000 (for
tissue fixed with 4% paraformaldehyde), and 1:40,000–1:100,000 (for
tissue fixed with 0.5% paraformaldehyde). After overnight incubation in
primary antibody and repeated washes in PBS containing 0.1% Tween 20
(PBS-T), the sections were reacted for 2 hr at room temperature with
biotinylated secondary antibody (1:200 in PBS) (Jackson ImmunoRe-
search, West Grove, PA). Biotin was localized by TSA (Renaissance
direct) (DuPont NEN, Wilmington, DE); tissue was incubated in PBS
containing 0.5% blocking reagent for 30 min, then incubated in
streptavidin-HRP (diluted 1:100 in PBS) for an additional 30 min. Three
washes with PBS-T were followed by a 5–7 min application of tyramide
conjugated to FITC or Cy3, diluted 1:50 in amplification diluent, and
then washed with PBS-T.
To obtain a better appreciation of the relationship between cellular
morphology and immunostaining, we used the membrane tracer DiA
(Molecular Probes, Eugene, OR), which labels even the finest neuronal
processes. DiA crystals were applied with a micropipette directly to some
of the immunostained sections, which were then stored at 4°C for 24–72
hr. Sections were mounted on gelatin-coated slides and either air-dried
and cleared with xylene before being coverslipped with Fluoromount
(Gurr BDH, Toronto, Canada) or directly coverslipped with Vectashield
mounting medium (Vector Laboratories).
Multiple labeling. The first primary antibody was amplified with TSA,
whereas the second and third primary antibodies were revealed with
conventional fluorescent staining (Hunyady et al., 1996; Shindler and
Roth, 1996). Sections were immunoprocessed for ABP as described
above. After the application of the dye-conjugated tyramide and prein-
cubation in 1% BSA in PBS-T, the second primary antibodies (either
GRIP or GluR2/3 antibody, at dilutions of 1:1,000–1:2,000 for material
fixed with 4% paraformaldehyde and 1:5,000–1:10,000, for material fixed
with 0.5% paraformaldehyde) were applied overnight. Immunoreactivity
was visualized with donkey anti-rabbit conjugated to rhodamine (Jack-
son ImmunoResearch). Sections labeled for ABP and GluR2/3 were then
processed for synaptophysin (clone SVP-38, 1:1,000) (Sigma) or DiA
labeling. Sections labeled for ABP and GRIP were then processed for
synaptophysin, GluR2/3 (goat antibody Sc-7610) (Santa Cruz Biotech-
nology, Santa Cruz, CA), or DiA.
For optimal z-axis resolution, semithin plastic sections were prepared
after immunofluorescence processing. Sections were then dehydrated
and flat-embedded in Lowicryl HM20 (Polysciences, Warrington, PA).
After polymerization, 1 mm sections were cut, heat-mounted on slides,
and coverslipped with Fluoromount.
To control for possible cross-reaction between the first primary anti-
body and the second secondary antibody (both raised in rabbit), the
tissue was processed as described above, except that the second primary
antibody was omitted. These sections were uniformly negative for the
staining of the secondary antibodies. Moreover, we obtained consistent
experimental results when the order of the first two primary antibodies
was reversed.
Microscopy and data analysis. Sections were examined with a Leitz
Figure 1. Immunostaining for ABP in cerebral cortex. A, Immunoper-
oxidase staining in 40-mm-thick tissue section, fixed with 4% paraformal-
dehyde. ABP immunoreactivity was found in neurons throughout all
layers of cortex. B, Detail from layer V. Arrow points to a pyramidal
neuron; staining is organized into patches in the soma and proximal part
of the apical dendrite (arrowheads). Inset shows a nonpyramidal neuron
with a characteristic ABP-intense pattern of staining concentrated at the
edge of the cell. Scale bars: A, 100 mm; B, 20 mm; inset, 10 mm.
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DMR microscope under bright field, Nomarski, or epifluorescence illu-
mination. Fluorescent images were acquired with a cooled charge-
coupled device camera (Princeton Instruments, Trenton, NJ) coupled to
a Macintosh computer. IP Lab software (Scanalytics, Fairfax, VA) was
used for image acquisition and initial processing. For optimal resolution
of thick sections, images were acquired with a Leica TCS confocal
microscope. With optical sectioning, it was possible with this instrument
to assess continuity of processes through the thickness of a section.
Quantification of puncta was performed on confocal images from
randomly selected cortical fields. Images were acquired with a 1003 oil
objective with a pinhole diameter of 1.3 optical units (OUs) and 13
magnification. Quantification of immunopositive spines identified by DiA
was performed on 25 mm confocal z-axis stacks, acquired with a 633 oil
objective with a pinhole diameter of 1.3 OU and 13 magnification.
We also used the confocal instrument as a photometer to assess
immunofluorescence staining of cells quantitatively. Randomly selected
cortical fields were displayed at high magnification on the Leica TCS host
computer screen. Neurons well defined by either ABP or GRIP immu-
nocytochemistry were outlined, and mean pixel values of the outlined
region were computed. Normalized immunofluorescence was computed
as [(mean pixel value of cell) 2 (mean pixel value of background)]/
[(mean pixel value of brightest cell measured on section) 2 (mean pixel
value of background)], yielding a dimensionless photometric value be-
tween 0 (immunofluorescence at background level) and 1 (the brightest
cell measured). We used Corel Draw v.9 (Corel, Ontario, Canada) to




Most neurons in cerebral cortex were immunopositive for ABP.
Both weakly and strongly stained neurons were present in all
cortical layers (Fig. 1A). Some of these could be identified as
pyramidal neurons (Fig. 1B); others were nonpyramidal cells of
various shapes and sizes. The degree of staining varied according
to cell type: pyramidal neurons were generally more intensely
Figure 2. ABP immunofluorescent stain-
ing after fixation with 0.5% paraformalde-
hyde. A, B, Intense patchy staining was
observed in somata (arrows) and den-
drites. C, Numerous immunoreactive
puncta were also present in the neuropil.
These puncta often showed juxtaposition
or partial overlap with synaptophysin
(Syn.)-positive terminals (arrowheads on
insets corresponding to the 3 boxes in main
panel) and were thus likely to correspond
to synapses. D, E, To elucidate the rela-
tionship of these puncta to cell processes,
we performed double labeling with the
membrane tracer DiA (in z-axis stack, as
illustrated by representative optical sec-
tions). Dense cellular staining of a small
pyramidal neuron (D, E, arrows) contrasts
with weaker ABP immunostaining in a
nonpyramidal neuron (asterisk). DiA
staining reveals that ABP concentrates at
spines; most of these are likely to be on
dendritic branches originating from pyra-
midal neurons (D, arrowheads; E, insets,
arrowheads), but a few are on sparsely
spiny dendrites of nonpyramidal neurons
(E, curved arrows). Scale bars: A, B, 10
mm; C, 20 mm; insets, 5 mm; D, E, 25 mm.
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stained for ABP than were nonpyramidal neurons. A few nonpy-
ramidal neurons (,1% of all labeled neurons) were particularly
intensely immunopositive, with a characteristic pattern of stain-
ing mainly restricted to the edge of the cell, at or adjacent to the
plasma membrane (Fig. 1B, inset). Although scattered through
the cortex, these neurons were most frequently encountered in
layers I–III. Except for these “ABP-intense” neurons, staining
was typically patchy within proximal dendrites and somatic cyto-
plasm, excluding the nucleus. Immunopositive puncta were ob-
served throughout the neuropil, particularly in layers I and II. We
interpret these puncta as dendritic branches cut in cross-section,
rather than immunoreactive synapses, because no clear associa-
tion with the presynaptic marker synaptophysin could be detected
in double-labeling experiments (data not shown).
The apparent lack of synaptic staining was unexpected, consid-
ering published evidence from postembedding immunoelectron
microscopy (Srivastava et al., 1998). We reasoned that if ABP acts
to anchor GluR2, it may be complexed with other proteins within
the postsynaptic density, thus limiting antibody access. To explore
whether there may be an occult synaptic pool of ABP only poorly
detected with standard preembedding methods, we performed
immunocytochemistry on sections pretreated with pepsin and on
tissue only weakly fixed with paraformaldehyde. With both tech-
niques, staining of puncta in the neuropil was considerably en-
hanced. Unfortunately, proteolytic treatment caused substantial
damage to tissue sections and impaired cytoplasmic staining. The
most satisfactory results were obtained from sections weakly fixed
by 0.5% paraformaldehyde (Fig. 2). This procedure markedly
increased the detection of antigen while suppressing background
and thus provided optimal visualization of the cellular and sub-
cellular distribution of ABP. In this material, intense patchy
staining was observed in somata and proximal dendrites and in
puncta throughout the neuropil (Fig. 2A,B). Double-labeling
experiments showed a close relationship between many of these
puncta and synaptophysin (Fig. 2C), indicating that weak fixation
by 0.5% paraformaldehyde allowed the detection of the synaptic
pool of ABP. Of 873 synaptophysin-positive puncta, 281 (32%)
were associated with an ABP-positive punctum. Conversely, of
Figure 3. Chart summarizing the quantitative data on synaptic localiza-
tion of ABP and its colocalization with GluR2/3 and GRIP. A, A close
relationship between ABP puncta and synaptophysin was observed in the
neuropil; 76% of ABP puncta showed juxtaposition or partial overlap with
a synaptophysin-positive punctum. B, Seventy-one percent of GluR2/3-
positive puncta were likely to be synaptic (as defined by synaptophysin),
and 65% of GluR2/3-positive spines (identified by DiA) were immunopo-
sitive for ABP. C, Of puncta likely to represent synapses (as defined by
synaptophysin) that were immunopositive for either ABP or GRIP, 40%
colocalized ABP and GRIP, 31% were selectively positive for ABP, and
28% were selectively positive for GRIP. Results were similar for dendritic
spines; of the spines immunopositive for either ABP or GRIP, 42% were
stained for both ABP and GRIP, 32% for ABP alone, and 26% for GRIP
alone.
Figure 4. Colocalization of ABP with GluR2/3. A, B, Double labeling for
ABP and GluR2/3 in layers I–II (A) and III (B), after fixation with 4%
paraformaldehyde. Most GluR2/3-positive cells contained ABP immuno-
reactivity (A, arrows), with the exception of scattered ABP-intense neu-
rons (arrowheads). In the neuropil, GluR2/3 puncta were seldom associ-
ated with ABP puncta after strong fixation. C, Double labeling for ABP
and GluR2/3 in a large pyramidal neuron of layer V, after fixation with
0.5% paraformaldehyde. In somata and proximal dendrites, ABP patches
were sometimes associated with GluR2/3 patches, but many GluR2/3
patches were distinct from ABP patches. In contrast with the labeling
after fixation with 4% paraformaldehyde, ABP-immunopositive puncta in
the neuropil usually also stained for GluR2/3 (arrows), although some
GluR2/3-positive puncta did not stain for ABP (arrowheads). Micrographs
are from a 30 mm frozen section (A), a 1-mm-thick plastic section (B), and
a 50 mm frozen section ( C). Scale bars: A, 50 mm; B, C, 20 mm.
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370 ABP-positive puncta, 281 (76%) showed juxtaposition or
partial overlap with a synaptophysin-positive punctum (Fig. 3A),
suggesting that most immunocytochemically identified ABP
puncta were synaptic. This synaptic localization was confirmed by
double labeling with the membrane tracer DiA, which showed
that many dendritic spines contain ABP (Fig. 2D,E).
Colocalization of ABP with AMPA receptor subunits
Previous studies have shown that ABP interacts with both GluR2
and GluR3 in vitro. If it also binds these subunits in vivo, one
would expect ABP immunostaining in neurons immunopositive
for GluR2/3. We therefore performed double labeling for ABP
and AMPA receptors using antibodies that recognized both
GluR2 and GluR3 subunits. Patterns of immunostaining for
GluR2/3 were similar to previous reports (Petralia and Wenthold,
1992). In the cerebral cortex, GluR2/3 antibodies stained somata
and dendrites of a large population of pyramidal cells and also
stained a substantial number of nonpyramidal cells. Double la-
beling showed that many GluR2/3-immunopositive neurons also
expressed high levels of ABP, but a substantial fraction expressed
ABP at low or undetectable levels. In contrast, the vast majority
of ABP-positive cells also stained for GluR2/3, with the exception
of the scattered ABP-intense neurons, which generally lacked
GluR2/3 (Fig. 4A,B).
In somata, patches of ABP immunoreactivity occasionally co-
localized with GluR2/3 patches, but more typically, these patches
seemed independently organized (Fig. 4C). Considering the
dense labeling for both antigens, the overall impression was of a
lack of association. In contrast, punctate colocalization of ABP
and GluR2/3 was often observed in the neuropil (Fig. 4B,C),
although some GluR2/3 puncta were immunonegative for ABP.
By combining immunolabeling with DiA, we could demonstrate
that although many dendritic spines were immunopositive for
both markers, many others were positive for GluR2/3 but not
ABP (Fig. 5).
To assess the relative frequencies of synapses of these two
types, we performed triple immunolabeling for GluR2/3, ABP,
and synaptophysin (data not shown). Of 522 GluR2/3-positive
puncta likely to be synaptic (as defined by synaptophysin), 373
(71%) were also immunopositive for ABP (Fig. 3B). Using a
second approach to identify putative synaptic labeling, we found
that of 54 GluR2/3-positive spines (identified by DiA), 35 (65%)
were also immunopositive for ABP (Fig. 3B). That a negative
spine could be adjacent to an immunopositive spine (Fig. 5B)
documents a high level of chemical heterogeneity, even within a
single dendritic twig.
Figure 5. Partial colocalization of ABP with GluR2/3 in spines. DiA
staining (A3) reveals spiny dendrites (boxed regions are shown at higher
magnification in B, C). Many of the spines are immunopositive for both
ABP and GluR2/3 (arrowheads), whereas others are positive for only
GluR2/3 (arrows). Scale bars: A, 10 mm; B, C, 2 mm.
Figure 6. Specificity of the ABP and
GRIP antibodies used in the present
study. A, Immunofluorescence for ABP.
B, Immunofluorescence for GRIP (1756/
B. O.). ABP was detected in HeLa cells
transfected with ABP (A, arrows), but not
in GRIP-transfected cells. Likewise,
GRIP was detected in GRIP-transfected
cells (B, arrowheads), but not in ABP-
transfected cells. Scale bars, 50 mm.
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Colocalization of ABP and GRIP
That ABP and GluR2/3 exhibit only partial colocalization sug-
gests that a sizable fraction of GluR2/3-positive synapses may lack
ABP. This led us to explore the relationship between ABP and
GRIP, another putative GluR2/3 scaffold. Because ABP (outside
its L2 region) is homologous to GRIP, there is the theoretical
possibility of cross-reaction between GRIP antisera and ABP. To
assess this possibility, we performed immunofluorescence on
transfected cells. ABP immunoreactivity was detected in ABP-
transfected cells, but not in GRIP-transfected cells (Fig. 6A).
Likewise, immunoreactivity for GRIP (antibody 1756/B.O.) was
detected in GRIP-transfected cells, but not in ABP-transfected
cells (Fig. 6B). These data suggest that there was no significant
cross-reaction between ABP and GRIP antibodies, at least at the
concentration used in this work. To verify the reliability of our
results, the observations reported below were qualitatively con-
firmed using a second GRIP antibody, prepared against a peptide
sequence not shared by ABP (deSouza and Ziff, unpublished
observations).
Cellular staining for GRIP was consistent with previous re-
ports (Wyszynski et al., 1998; Burette et al., 1999; Dong et al.,
1999): GRIP stained dendrites and somata of nonpyramidal neu-
rons scattered throughout cortex, and pyramidal cells were only
weakly immunopositive. Most GRIP-positive cells also contained
ABP, and vice versa (Fig. 7A). Cells strongly immunopositive for
ABP (mainly pyramidal neurons) were weakly stained for GRIP,
whereas cells strongly immunopositive for GRIP (a subset of
nonpyramidal neurons) were weakly stained for ABP; in contrast,
the scattered ABP-intense neurons were usually strongly positive
for both proteins (Fig. 7A). Photometry of cells from random
high-power fields (see Materials and Methods) confirmed this
impression (Fig. 8): immunofluorescence for ABP was signifi-
cantly ( p , 0.001; two-sided t test) stronger for pyramidal cells
(mean normalized brightness, 0.640 6 0.040; n 5 23) than for
nonpyramidal neurons (0.286 6 0.033; n 5 32), whereas immu-
nofluorescence for GRIP was significantly ( p , .001) weaker for
pyramidal cells (0.360 6 0.039) than for other neurons (0.629 6
0.033).
Subcellular colocalization was not the rule within the cell body;
intrasomatic patches of ABP immunoreactivity were generally
distinct from patches stained for GRIP (Fig. 7B,C). In some
cases, ABP and GRIP were differentially distributed within a
single dendritic arborization: the proximal dendrite was stained
for both proteins, but secondary dendrites were stained for either
ABP or GRIP alone (Fig. 7B,C). Beyond suggesting differential
Figure 7. Partial immunocolocalization of ABP with GRIP. A, Double
labeling for ABP and GRIP in the cerebral cortex; tissue fixed with 4%
paraformaldehyde. Most ABP-positive cells contained GRIP immunoreac-
tivity, and vice versa. However, cells strongly immunopositive for ABP (small
arrows) were weakly stained for GRIP, whereas cells strongly immunoposi-
tive for GRIP (arrowheads) were weakly stained for ABP. Scattered ABP-
intense neurons were strongly positive for both proteins (curved arrows). B, C,
Double labeling for ABP and GRIP after fixation with 0.5% paraformalde-
hyde. Intrasomatic patches of ABP immunoreactivity were generally distinct
from patches of GRIP. A differential distribution of ABP and GRIP was
often observed within the dendritic arborization. B, A proximal dendrite and
one of its branches (arrows) were stained for both proteins, but the other
branch was stained for GRIP alone (arrowheads). C, The proximal apical
dendrite was stained for both proteins (arrows), but more distal regions were
stained for ABP alone (arrowheads); likewise, the proximal basal dendrite
was stained for both proteins (arrows), but distal branches were stained for
GRIP alone (arrowheads). Insets show that many puncta in the neuropil
colocalized both ABP and GRIP (arrowheads), but a number of puncta were
selectively positive for either GRIP or ABP. Scale bars: A, 50 mm; B, C, 10
mm; inset, 5 mm.
Figure 8. Relative intensities of ABP and GRIP immunofluorescence in
cerebral cortex. Intensity of somatic labeling was measured in 103 neurons
spanning all cortical layers from a representative double-stained section.
Confocal images were captured, and mean photometric intensities of red
and green channels were computed for each that was well defined in either
channel; data were normalized from 0 (tissue background) to 1 (brightest
cell measured) for each channel. Open triangles represent morphologically
identified pyramidal cells, filled circles represent nonpyramidal neurons,
and dots represent neurons that could not be clearly identified. The two
types of neurons form distinct clusters; pyramidal neurons generally
stained strongly for ABP and not for GRIP, whereas nonpyramidal
neurons stained strongly for GRIP and not for ABP. Outlying cells, top
right, were exceptionally large. A cluster of cells near the origin was
stained too weakly to permit clear identification.
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transport and/or targeting of the two proteins, these data provide
further evidence that the two antibodies recognized different
antigens.
Of puncta immunopositive for either ABP or GRIP, we iden-
tified 683 that were likely to represent synapses because they
either overlapped or were adjacent to synaptophysin-positive
puncta. Of these, 274 (40%) colocalized ABP and GRIP, 216
(31%) were selectively positive for ABP, and 193 (28%) were
selectively positive for GRIP (Fig. 3C). Consistent with this
finding, of 53 spines immunopositive for either ABP or GRIP (as
revealed by DiA staining), 22 (42%) were stained for both ABP
and GRIP, 17 (32%) for ABP alone, and 14 (26%) for GRIP
alone (Figs. 3C, 8A,B). The three types of immunostaining (i.e.,
ABP only, GRIP only, and colocalization of both) could be
observed on adjacent spines of the same dendrite (Fig. 9A,B).
These results, together with the quantitative data on ABP stain-
ing of GluR2/3-positive synapses described above, are consistent
with the possibility that all GluR2/3-positive synapses contain
either ABP or GRIP or both. We then examined spines triple-
labeled with GluR2/3, ABP, and GRIP. This combination of
labeling required histochemical procedures that yielded subopti-
mal staining, but we were able to confirm colocalization of
GluR2/3-positive spines with both of these scaffolding proteins in
different combinations (Fig. 9C,D).
DISCUSSION
Using multiple-label immunocytochemistry, we have character-
ized the cellular and subcellular expression of ABP and its
relationships with GluR2/3 and GRIP. Immunostaining for ABP
in the cerebral cortex was strong in pyramidal neurons and
weaker in nonpyramidal neurons. All three antigens were also
found at synapses, but only after proteolytic pretreatment or in
weakly fixed tissue, suggesting that ABP/GRIP may be so tightly
complexed with AMPA receptors and other proteins at the syn-
apse that antibody access is severely restricted (Ye et al., 2000).
Figure 9. Partial colocalization of ABP
with GRIP in GluR2/3-immunoreactive
spines. A, B, DiA staining reveals a pyra-
midal neuron stained for both ABP and
GRIP. B, Higher-magnification view of
spiny dendrites shown in A. Some spines
are immunopositive for both ABP and
GRIP (curved arrows), whereas others are
immunopositive for ABP alone (straight
arrows) or GRIP alone (arrowheads).
Note that spines with two different chem-
ical profiles originate from the same den-
drite. C, D, Triple immunostaining for
ABP, GRIP, and GluR2/3. C, Two verti-
cally directed dendrites are visible on the
right. One is immunopositive for GRIP
and GluR2/3 (arrowheads) but shows vir-
tually no staining for ABP. The other
(boxed areas) is immunostained for all
three antigens. D, Enlargement of boxed
areas shows GluR2/3-positive spines im-
munopositive for both ABP and GRIP
(curved arrows), for ABP only (straight
arrows), and GRIP only (arrowheads),
all associated with the same dendrite.
Scale bars: A, 10 mm; B, 50 mm; C, 20 mm;
D, 3 mm.
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ABP associates with GluR2/3 in vivo
In vitro evidence suggests a role for ABP in anchoring AMPA
receptors. Yeast two-hybrid assays show that ABP can bind via its
PDZ domains 3, 5, and 6 to the C termini of GluR2 and GluR3;
furthermore, ABP copurifies with GluR2 in the PSD fraction of
brain homogenate (Srivastava et al., 1998). The multiple labeling
experiments reported here are consistent with the idea that ABP
and GluR2/3 interact in vivo. Although ABP is expressed almost
exclusively in GluR2/3-containing neurons, high-resolution im-
ages show little subcellular colocalization of the two antigens in
somata and proximal dendrites. In contrast, colocalization in the
neuropil is prominent, and a large fraction of this colocalization
is likely to be synaptic, as shown by its association with dendritic
spines and with synaptophysin. Together, these observations sug-
gest that ABP is not involved in cytoplasmic receptor trafficking,
but may play an important role at or near the synapse. The role
of ABP in the small group of ABP-intense, GluR2/3-negative
cells remains unclear. For their morphology, location, and intense
staining for GRIP, we suspect that these are likely to represent a
specialized population of GluR1-rich GABAergic interneurons
(Burette et al., 1999), suggesting that ABP and GRIP play some
scaffolding role unrelated to GluR2/3 in these neurons.
ABP and GRIP are differentially expressed
Notwithstanding extensive cellular colocalization of GRIP and
ABP, the relative intensity of labeling for the two antigens varied:
cells strongly immunopositive for ABP (mainly pyramidal neu-
rons) were typically weakly stained for GRIP, whereas cells
strongly immunopositive for GRIP (mainly nonpyramidal neu-
rons) were weakly stained for ABP. Sparsely spiny or aspiny
dendrites likely to originate from nonpyramidal neurons (and
previously shown to express GRIP at high levels) (Burette et al.,
1999) typically contained markedly less ABP than did spiny
dendrites.
We used both dendritic spines and synaptophysin as light
microscopic proxies to investigate patterns of synaptic colocaliza-
tion. Both proxies are dominated by pyramidal neurons: spines
originate overwhelmingly from pyramidal neurons, but even a
random sample of asymmetric synapses (as revealed by synapto-
physin) will be dominated by axospinous synapses, considering
the relative infrequency of excitatory synapses on dendritic shafts
in neocortex (Feldman, 1984). Keeping this caveat in mind, our
data suggest that although many of these synapses contained both
GRIP and ABP, the majority were positive for only one of the
proteins. Thus, ABP and GRIP must be independently regulated;
that the three types of immunostaining (ABP only, GRIP only,
and colocalization) could be observed on adjacent spines of the
same dendrite shows that this regulation is very tight indeed.
Notwithstanding the differential distribution of the two antigens,
we conclude from the present results that most, or perhaps all,
GluR2/3-containing synapses in cerebral cortex include either
ABP or GRIP.
Possible functional implications
Synaptic AMPA receptors appear to be more firmly anchored at
GABAergic (nonpyramidal) cells than at pyramidal neurons (Al-
lison et al., 1998). In the light of the present evidence, this
suggests that AMPA receptors are less mobile at GRIP-enriched
synapses than at ABP-enriched synapses. This raises the possi-
bility that GRIP might bind GluR2/3 more firmly than does ABP;
it would be interesting to test this hypothesis directly. Heterolo-
gous expression experiments suggest that ABP and GRIP may
copolymerize to form large scaffolds within the PSD (Srivastava
et al., 1998; Dong et al., 1999), leading to the more general
hypothesis that the ratio of ABP/GRIP may control the mobility
of GluR2/3 within the synapse. Because addition of new AMPA
receptors to the synapse may underlie some forms of long-term
potentiation (LTP) (for review, see Malinow, 1998; Malenka and
Nicoll, 1999; Turrigiano, 2000), the limited available evidence
suggesting more robust LTP in pyramidal than in nonpyramidal
neurons (McMahon and Kauer, 1997; Laezza et al., 1999; McBain
et al., 1999) is consistent with this hypothesis.
In addition to their role as receptor anchors, both GRIP and
ABP are likely to act as a molecular scaffold, organizing intra-
cellular second-messenger cascades. Notwithstanding their close
homology (64–93% in their six PDZ domains), it seems likely
that the two proteins have different binding affinities for intracel-
lular kinases and phosphatases that may be important in synaptic
plasticity (Torres et al., 1998; Bhalla and Iyengar, 1999; Bruckner
et al., 1999; Bloomfield and Ziff, 2000; Soderling and Derkach,
2000) (M. Wyszynski and M. Sheng, unpublished observations).
Interestingly, the novel RasGEF GRASP-1 binds to the seventh
PDZ domain of GRIP and its ABP homolog, ABP-L, but not to
ABP (which lacks the seventh PDZ domain) (Ye et al., 2000),
suggesting functional consequences of ABP splice variant regu-
lation. The present research points to the need for further study
of potential intracellular binding partners for these scaffolding
molecules.
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